NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14).

For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.